Cargando…
Crocetin as New Cross-Linker for Bioactive Sericin Nanoparticles
The nose-to-brain delivery route is used to bypass the blood–brain barrier and deliver drugs directly into the brain. Over the years, significant signs of progress have been made in developing nano-drug delivery systems to address the very low drug transfer levels seen with conventional formulations...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150760/ https://www.ncbi.nlm.nih.gov/pubmed/34065101 http://dx.doi.org/10.3390/pharmaceutics13050680 |
_version_ | 1783698224155983872 |
---|---|
author | Perteghella, Sara Rassu, Giovanna Gavini, Elisabetta Obinu, Antonella Bari, Elia Mandracchia, Delia Bonferoni, Maria Cristina Giunchedi, Paolo Torre, Maria Luisa |
author_facet | Perteghella, Sara Rassu, Giovanna Gavini, Elisabetta Obinu, Antonella Bari, Elia Mandracchia, Delia Bonferoni, Maria Cristina Giunchedi, Paolo Torre, Maria Luisa |
author_sort | Perteghella, Sara |
collection | PubMed |
description | The nose-to-brain delivery route is used to bypass the blood–brain barrier and deliver drugs directly into the brain. Over the years, significant signs of progress have been made in developing nano-drug delivery systems to address the very low drug transfer levels seen with conventional formulations (e.g., nasal solutions). In this paper, sericin nanoparticles were prepared using crocetin as a new bioactive natural cross-linker (NPc) and compared to sericin nanoparticles prepared with glutaraldehyde (NPg). The mean diameter of NPc and NPg was about 248 and 225 nm, respectively, and suitable for nose-to-brain delivery. The morphological investigation revealed that NPc are spherical-like particles with a smooth surface, whereas NPg seem small and rough. NPc remained stable at 4 °C for 28 days, and when freeze-dried with 0.1% w/v of trehalose, the aggregation was prevented. The use of crocetin as a natural cross-linker significantly improved the in vitro ROS-scavenging ability of NPc with respect to NPg. Both formulations were cytocompatible at all the concentrations tested on human fibroblasts and Caco-2 cells and protected them against oxidative stress damage. In detail, for NPc, the concentration of 400 µg/mL resulted in the most promising to maintain the cell metabolic activity of fibroblasts higher than 90%. Overall, the results reported in this paper support the employment of NPc as a nose-to-brain drug delivery system, as the brain targeting of antioxidants is a potential tool for the therapy of neurological diseases. |
format | Online Article Text |
id | pubmed-8150760 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81507602021-05-27 Crocetin as New Cross-Linker for Bioactive Sericin Nanoparticles Perteghella, Sara Rassu, Giovanna Gavini, Elisabetta Obinu, Antonella Bari, Elia Mandracchia, Delia Bonferoni, Maria Cristina Giunchedi, Paolo Torre, Maria Luisa Pharmaceutics Article The nose-to-brain delivery route is used to bypass the blood–brain barrier and deliver drugs directly into the brain. Over the years, significant signs of progress have been made in developing nano-drug delivery systems to address the very low drug transfer levels seen with conventional formulations (e.g., nasal solutions). In this paper, sericin nanoparticles were prepared using crocetin as a new bioactive natural cross-linker (NPc) and compared to sericin nanoparticles prepared with glutaraldehyde (NPg). The mean diameter of NPc and NPg was about 248 and 225 nm, respectively, and suitable for nose-to-brain delivery. The morphological investigation revealed that NPc are spherical-like particles with a smooth surface, whereas NPg seem small and rough. NPc remained stable at 4 °C for 28 days, and when freeze-dried with 0.1% w/v of trehalose, the aggregation was prevented. The use of crocetin as a natural cross-linker significantly improved the in vitro ROS-scavenging ability of NPc with respect to NPg. Both formulations were cytocompatible at all the concentrations tested on human fibroblasts and Caco-2 cells and protected them against oxidative stress damage. In detail, for NPc, the concentration of 400 µg/mL resulted in the most promising to maintain the cell metabolic activity of fibroblasts higher than 90%. Overall, the results reported in this paper support the employment of NPc as a nose-to-brain drug delivery system, as the brain targeting of antioxidants is a potential tool for the therapy of neurological diseases. MDPI 2021-05-09 /pmc/articles/PMC8150760/ /pubmed/34065101 http://dx.doi.org/10.3390/pharmaceutics13050680 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Perteghella, Sara Rassu, Giovanna Gavini, Elisabetta Obinu, Antonella Bari, Elia Mandracchia, Delia Bonferoni, Maria Cristina Giunchedi, Paolo Torre, Maria Luisa Crocetin as New Cross-Linker for Bioactive Sericin Nanoparticles |
title | Crocetin as New Cross-Linker for Bioactive Sericin Nanoparticles |
title_full | Crocetin as New Cross-Linker for Bioactive Sericin Nanoparticles |
title_fullStr | Crocetin as New Cross-Linker for Bioactive Sericin Nanoparticles |
title_full_unstemmed | Crocetin as New Cross-Linker for Bioactive Sericin Nanoparticles |
title_short | Crocetin as New Cross-Linker for Bioactive Sericin Nanoparticles |
title_sort | crocetin as new cross-linker for bioactive sericin nanoparticles |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150760/ https://www.ncbi.nlm.nih.gov/pubmed/34065101 http://dx.doi.org/10.3390/pharmaceutics13050680 |
work_keys_str_mv | AT perteghellasara crocetinasnewcrosslinkerforbioactivesericinnanoparticles AT rassugiovanna crocetinasnewcrosslinkerforbioactivesericinnanoparticles AT gavinielisabetta crocetinasnewcrosslinkerforbioactivesericinnanoparticles AT obinuantonella crocetinasnewcrosslinkerforbioactivesericinnanoparticles AT barielia crocetinasnewcrosslinkerforbioactivesericinnanoparticles AT mandracchiadelia crocetinasnewcrosslinkerforbioactivesericinnanoparticles AT bonferonimariacristina crocetinasnewcrosslinkerforbioactivesericinnanoparticles AT giunchedipaolo crocetinasnewcrosslinkerforbioactivesericinnanoparticles AT torremarialuisa crocetinasnewcrosslinkerforbioactivesericinnanoparticles |